Skip to main content

Table 1 Patient baseline characteristics

From: Relation of atherogenic lipoproteins with estimated glomerular filtration rate decline: a longitudinal study

 

Total (N = 400)

Age

58 (52, 63)

Gender (%)

 

Men

49

Women

51

Race (%)

 

White

58

Black

36

Other

6

Hypertension (%)

73

Systolic BP (mmHg)

128 (118, 136)

Diastolic BP (mmHg)

75 (70, 80)

Waist Circumference (in)

42 (38, 46)

BMI (kg/m2)

31.7 (28.0, 36.2)

Glucose (mg/dL)

112 (95, 139)

Hemoglobin A1c (%)

6.7 (6.2, 7.5)

Serum Creatinine (mg/dL)

0.88 (0.70, 1.0)

BUN (mg/dL)

16 (13, 19)

eGFR (CKD-EPI)

91.7 (80.0, 102.1)

Urinary ACR (mg/g)

5.3 (3, 13.5)

Anti-Hypertensive Medications (%)

 

ACE Inhibitor or ARB

61

Diuretic

32

CCB

16

Beta Blocker

12

Lipid-Lowering Medications (%)

 

Statin

52

Fibrate

7

Niacin

4

Lp(a) (mg/dL)

25 (9, 57)

ApoC-III (mg/dL)*

11.4 (8.7, 15.6)

Triglycerides (mg/dL)

105 (79, 156)

LDL-C (mg/dL)

99 (79, 119)

Apolipoprotein B (mg/dL)

80 (69, 94)

  1. Characteristics of cohort at baseline visit. All data reported as median (interquartile range) unless otherwise specified
  2. BP blood pressure, BMI body mass index, BUN blood urea nitrogen, eGFR estimated glomerular filtration rate, ACR albumin to creatinine ratio, ARB angiotensin receptor blocker, CCB calcium channel blocker, Lp(a) lipoprotein(a), ApoC-III apolipoprotein C-III, LDL-C low density lipoprotein cholesterol
  3. *N = 336